Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

BACKGROUND: While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the SEISMIC (Study of the Efficacy and Safety of Mifepristone in the Treatment of E...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, David R., East, Honey E., Eilerman, Bradley S., Gordon, Murray B., King, Elizabeth E., Knecht, Laura A., Salke, Brandon, Samson, Susan L., Yuen, Kevin C. J., Yau, Hanford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596972/
https://www.ncbi.nlm.nih.gov/pubmed/33292727
http://dx.doi.org/10.1186/s40842-020-00105-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596972/
https://www.ncbi.nlm.nih.gov/pubmed/33292727
http://dx.doi.org/10.1186/s40842-020-00105-4

Ejemplares similares